Pharma AI startup Katalyze has secured $10.5 million in funding to explore the application of agentic AI technologies on pharmaceutical manufacturing plant floors. The company aims to determine whether autonomous AI agents can effectively operate in and optimize pharmaceutical production environments. This funding round reflects growing investor interest in AI solutions tailored to industrial and regulated manufacturing sectors.
Search
